JiangSu WuZhong Pharmaceutical Development Co., Ltd. (600200.SS)
CNY 9.85
(0.92%)
CNY 9.85
(0.92%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -200.93 Million | 56.27 Million | 447.64 Million | -414.55 Million | -166.02 Million | 334.02 Million |
| Net Income | -71.94 Million | -78.23 Million | 20.64 Million | -507.59 Million | 61.76 Million | -282.32 Million |
| Depreciation & Amortization | 47.52 Million | 47.63 Million | 49.75 Million | 83.43 Million | 86.52 Million | 89.47 Million |
| Deferred income taxes | -125.79 Thousand | 565.75 Thousand | -942.8 Thousand | 17.5 Thousand | 1.14 Million | -17.94 Million |
| Stock-based compensation | 8.16 Million | 12.61 Million | - | - | - | - |
| Change in working capital | -236.03 Million | 9.63 Million | 432.56 Million | -453.11 Million | -229.84 Million | 358.28 Million |
| Other non-cash items | 390.74 Million | 64.05 Million | -55.31 Million | 462.71 Million | -84.46 Million | 168.59 Million |
| Investing Cash Flow | 356.15 Million | 61.33 Million | 43.27 Million | 235.69 Million | 273.06 Million | -658.66 Million |
| Investments in PPE | -82.58 Million | -41.72 Million | -24.81 Million | -44.24 Million | -97.48 Million | -238.08 Million |
| Acquisitions | 231.4 Thousand | - | -8.49 Million | 14.08 Million | 194.49 Million | 566.65 Thousand |
| Investment purchases | -84.8 Million | -120 Million | -260.61 Million | -10 Million | -9595.18 | -370 Million |
| Sales/Maturities of investments | 303 Million | 22.26 Million | 142.77 Million | 17.95 Million | 35.1 Million | 278.85 Million |
| Other Investing Activities | 220.3 Million | 200.79 Million | 194.4 Million | 257.9 Million | 140.96 Million | -329.99 Million |
| Financing Cash Flow | 123.84 Million | 114.73 Million | -45.84 Million | 235.86 Million | -8.32 Million | 50.8 Million |
| Debt repayment | -54.29 Million | -1.06 Billion | -1.39 Billion | -1.48 Billion | -1.42 Billion | -906.85 Million |
| Dividends payments | -67.85 Million | -71.19 Million | -62.49 Million | -62.74 Million | -52.46 Million | -75.91 Million |
| Common Stock Repurchased | - | - | - | - | -40.04 Million | - |
| Common Stock Issuance | - | - | - | - | 40.04 Million | - |
| Other Financing Activities | 178.14 Million | 1.25 Billion | 1.41 Billion | 1.78 Billion | 1.47 Billion | 1.03 Billion |
| Accounts receivables | -257.34 Million | -169.23 Million | 395.78 Million | -1.92 Billion | -1.38 Billion | 78.65 Million |
| Accounts payables | 18.07 Million | 166 Million | 12.95 Million | 1.4 Billion | 1.12 Billion | 433.08 Million |
| Inventory | 3.22 Million | 12.3 Million | 24.77 Million | 59.29 Million | 28.21 Million | -135.5 Million |
| Other working capital | 8.1 Million | 565.75 Thousand | -942.8 Thousand | 17.51 Thousand | 1.14 Million | 493.79 Million |
| Cash at beginning of period | 1.47 Billion | 1.09 Billion | 645.61 Million | 588.61 Million | 490.21 Million | 764.65 Million |
| Cash at end of period | 1.71 Billion | 1.32 Billion | 1.09 Billion | 645.61 Million | 588.61 Million | 490.21 Million |
| Capital Expenditure | -82.58 Million | -41.72 Million | -24.81 Million | -44.24 Million | -97.48 Million | -238.08 Million |
| Effect of forex changes on cash | -128.1 Thousand | -147.79 Thousand | -4393.57 | -6340.08 | -318.42 Thousand | -598.57 Thousand |
| Net cash flow / Change in cash | 235.72 Million | 232.19 Million | 445.06 Million | 56.99 Million | 98.39 Million | -274.43 Million |
| Free Cash Flow | -283.51 Million | 14.55 Million | 422.83 Million | -458.8 Million | -263.5 Million | 95.93 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 20.62 Million | 19.39 Million | 5.05 Million | -82.89 Million | -71.94 Million | -16.44 Million |
| Depreciation & Amortization | - | 12.86 Million | 12.86 Million | 11.96 Million | 47.52 Million | -22.55 Million |
| Deferred income taxes | - | - | - | - | -125.79 Thousand | -143.55 Million |
| Stock-based compensation | - | 2.46 Million | - | 8.16 Million | 8.16 Million | -5.32 Million |
| Change in working capital | - | 125.56 Million | - | -246.01 Million | -236.03 Million | 171.43 Million |
| Other non-cash items | -323.11 Million | 139.49 Million | 1.46 Million | 180.46 Million | 390.74 Million | -148.16 Million |
| Investing Cash Flow | -40.68 Million | -8.79 Million | -110.14 Million | 66.97 Million | 356.15 Million | 98.08 Million |
| Investments in PPE | -11.91 Million | -7.58 Million | -18.5 Million | -20.08 Million | -82.58 Million | -7.52 Million |
| Acquisitions | -22.8 Million | -95.11 Million | - | -2.49 Million | 231.4 Thousand | 110.27 Thousand |
| Investment purchases | -6 Million | 93.16 Million | -104.16 Million | - | -84.8 Million | -84 Million |
| Sales/Maturities of investments | - | 744.46 Thousand | 6.8 Million | 88.5 Million | 303 Million | 181.5 Million |
| Other Investing Activities | 31.2 Thousand | 93.96 Million | 5.71 Million | 1.05 Million | 220.3 Million | 7.99 Million |
| Financing Cash Flow | -17.94 Million | -48.46 Million | 90.4 Million | -71.61 Million | 123.84 Million | 75.53 Million |
| Debt repayment | -45.58 Million | -23.99 Million | -46 Million | -273.24 Million | -54.29 Million | -676.63 Million |
| Dividends payments | -16.93 Million | -17.83 Million | -21.37 Million | -11.79 Million | -67.85 Million | -22.49 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | 44.57 Million | -24.47 Million | 65.77 Million | 201.63 Million | 178.14 Million | 774.66 Million |
| Accounts receivables | - | 114.49 Million | - | -257.34 Million | -257.34 Million | 166.16 Million |
| Accounts payables | - | - | - | - | 18.07 Million | - |
| Inventory | - | 8.59 Million | - | 3.22 Million | 3.22 Million | 5.27 Million |
| Other working capital | - | 2.46 Million | - | 8.1 Million | 8.1 Million | -5.32 Million |
| Cash at beginning of period | 1.67 Billion | 1.65 Billion | 1.6 Billion | 1.62 Billion | 1.47 Billion | 1.51 Billion |
| Cash at end of period | 1.31 Billion | 1.78 Billion | 1.58 Billion | 1.71 Billion | 1.71 Billion | 1.52 Billion |
| Capital Expenditure | -11.91 Million | -7.58 Million | -18.5 Million | -20.08 Million | -82.58 Million | -7.52 Million |
| Effect of forex changes on cash | 362.03 Thousand | -110.70 | 7.69 | -128.33 Thousand | -128.1 Thousand | -26.15 |
| Net cash flow / Change in cash | -360.75 Million | 124.24 Million | -13.21 Million | 91.98 Million | 235.72 Million | 8.99 Million |
| Free Cash Flow | -314.4 Million | 138.43 Million | -11.97 Million | 65.5 Million | -283.51 Million | -172.14 Million |
AT1
8155
8904
HRI
AITUF
248070